Up to 20% of people will develop urticaria at some stage in their lifetime.
Most people with urticaria do not require routine testing, including allergy testing, as their symptoms are not due to an IgE-mediated reaction. Testing is guided by history and "red flags", if present.
Allergy testing including specific IgE testing (RASTs) is not indicated for idiopathic (spontaneous) urticaria, particularly aeroallergen testing and mixed food RASTs.
For chronic spontaneous urticaria, medical therapy includes:
- Second generation H1 receptor antagonists, which can be titrated to 4 tablets per day
- H2 receptor antagonists e.g. famotidine
- Montelukast 10mg daily.
Short courses of corticosteroids can be considered for refractory severe cases and are not recommended as a first line therapy.
HealthPathways provides information on urticaria and angioedema assessment and management. ASCIA also provides resources for patients and health professionals.
Referrals for the PAH Allergy service will be accepted for idiopathic urticaria which has not adequately responded to medical therapy.